Prediction of Duration of Mechanical Ventilation in Acute Hypoxemic Respiratoty Failure (PREMIER)

March 7, 2025 updated by: Jesus Villar

Prediction of Duration of Mechanical Venylation in Patients Wit Acute Hypoxemic Respiratory Failure Usinf Machine Learning Approaches

Acute hypoxemic respiratory failure (AHRF) is a common cause of admission in intensive care units (ICUs) worldwide. We will assess machine learning (ML) techniques for prediction of prolonged duration (> or = to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. The study was registered with ClinalTrials.gov (NCT03145974). Our aim is to identify a model with the minimum number of variables that predict duration of prolonged ventilation in AHRF patients using data as early as from the first 48 hours with machine learning algorithms.

Study Overview

Detailed Description

Acute hypoxemic respiratory failure (AHRF) is the most common cause of admission in intensive care units (ICUs) worldwide. The investigators will assess the value of machine learning (ML) techniques for prediction of prolonged duration (> or equeal to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. Few studies have investigated the prediction of prolonged MV in patients with AHRF.

For model training and testing, the investigators will extract data from random pateints from the first 2 days after diagnosis of AHRF. The investigators had a database with 2,000,000 anonymized and dissociated demographics and clinically relevant data from 1,241 patients with AHRF from 22 hospitals in Spain. The investigators will follow the TRIPOD guidelines for prediction models. The investigators will screen relevant collected variables using a genetic algorithm variable selection to achieve parsimony. We will use 5-fold corss-validation in the data set of patients with data at T0, T24 and T48. We will use 25% of patients randomly selected for evaluation of the model.

Study Type

Observational

Enrollment (Actual)

1241

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain
        • Hospital Universitario La Paz
    • Las Palmas
      • Las Palmas de Gran Canaria, Las Palmas, Spain, 35019
        • Hospital Dr. Negrín

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

De-identified dataset inclusing 1241 ventilated patients with AHRF admitted in a network of Spainisg ICUs.

Description

Inclusion Criteria:

  • enotracheal intubation puls mechanical ventilation
  • PaO2/FiO2 ratio <or = 300 mmHg under MV with PEEP >or =5 and FiO2 >or = 0.3

Exclusion Criteria:

  • Brain death patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Derivation/testing cohort
The investigators will use a chort of 75% of patients, randomly selected, with data at T0, T24 and T48 after diagnosis of acute hypoxemic respiratory failure (AHRF). We will apply machine learning approaches.
Machine learning and logistic regression for the validation cohort
Validation hohort
we will use 25% of unseen patients, randomly selected, with data at T0, T24 and T48 after diagnosis of AHRF.
Machine learning and logistic regression for the validation cohort

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MV duration
Time Frame: up to 100 weeks
duration of mechanical ventilation
up to 100 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Jesus Villar, Fundación Canaria Instituto de Investigación Sanitaria de Canarias

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2025

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

February 3, 2025

First Submitted That Met QC Criteria

February 3, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 7, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Ethical reasons

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Hypoxemic Respiratory Failure

Clinical Trials on Machine learning and logistic regression for the training/testing cohort and validation cohort

Subscribe